At the Heart of Genome Editing and Cardiovascular Diseases

Reyna Hernández-Benítez; Maria Llanos Martinez-Martinez; Jeronimo Lajara; Pierre J. Magistretti; Nuria Montserrat; Juan Carlos Izpisua Belmonte

doi:10.1161/circresaha.118.312676

At the Heart of Genome Editing and Cardiovascular Diseases

Reyna Hernández-Benítez, Maria Llanos Martinez-Martinez, Jeronimo Lajara, Pierre J. Magistretti, Nuria Montserrat, Juan Carlos Izpisua Belmonte

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Cardiovascular disease (CVD) is still the leading cause of death worldwide, but the knowledge and technologies for counteracting this disease may already be in our hands. Scientific advances over the past few years, such as the isolation and differentiation of induced pluripotent stem cells, and the development of gene-editing tools, have enabled us to model CVD, but more importantly, may represent tools for CVD early diagnosis, patient stratification, and treatment.

Original language	English (US)
Pages (from-to)	221-223
Number of pages	3
Journal	Circulation Research
Volume	123
Issue number	2
DOIs	https://doi.org/10.1161/circresaha.118.312676
State	Published - Jul 5 2018

Bibliographical note

KAUST Repository Item: Exported on 2020-10-01
Acknowledgements: Work in the laboratory of J.C. Izpisua Belmonte was supported by G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust, The Moxie Foundation, King Abdullah University of Science and Technology, and Universidad Católica San Antonio de Murcia.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1161/circresaha.118.312676

https://repository.kaust.edu.sa/bitstream/10754/628249/1/Hernandez-Benitez%20et%20al.%2c%202018-KAUST.pdf

Cite this

@article{c19381637fe449be98c2a3173c4ecf30,

title = "At the Heart of Genome Editing and Cardiovascular Diseases",

abstract = "Cardiovascular disease (CVD) is still the leading cause of death worldwide, but the knowledge and technologies for counteracting this disease may already be in our hands. Scientific advances over the past few years, such as the isolation and differentiation of induced pluripotent stem cells, and the development of gene-editing tools, have enabled us to model CVD, but more importantly, may represent tools for CVD early diagnosis, patient stratification, and treatment.",

author = "Reyna Hern{\'a}ndez-Ben{\'i}tez and Martinez-Martinez, {Maria Llanos} and Jeronimo Lajara and Magistretti, {Pierre J.} and Nuria Montserrat and {Izpisua Belmonte}, {Juan Carlos}",

note = "KAUST Repository Item: Exported on 2020-10-01 Acknowledgements: Work in the laboratory of J.C. Izpisua Belmonte was supported by G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust, The Moxie Foundation, King Abdullah University of Science and Technology, and Universidad Cat{\'o}lica San Antonio de Murcia.",

year = "2018",

month = jul,

day = "5",

doi = "10.1161/circresaha.118.312676",

language = "English (US)",

volume = "123",

pages = "221--223",

journal = "Circulation Research",

issn = "0009-7330",

publisher = "American Heart Association",

number = "2",

}

TY - JOUR

T1 - At the Heart of Genome Editing and Cardiovascular Diseases

AU - Hernández-Benítez, Reyna

AU - Martinez-Martinez, Maria Llanos

AU - Lajara, Jeronimo

AU - Magistretti, Pierre J.

AU - Montserrat, Nuria

AU - Izpisua Belmonte, Juan Carlos

N1 - KAUST Repository Item: Exported on 2020-10-01 Acknowledgements: Work in the laboratory of J.C. Izpisua Belmonte was supported by G. Harold and Leila Y. Mathers Charitable Foundation, The Leona M. and Harry B. Helmsley Charitable Trust, The Moxie Foundation, King Abdullah University of Science and Technology, and Universidad Católica San Antonio de Murcia.

PY - 2018/7/5

Y1 - 2018/7/5

N2 - Cardiovascular disease (CVD) is still the leading cause of death worldwide, but the knowledge and technologies for counteracting this disease may already be in our hands. Scientific advances over the past few years, such as the isolation and differentiation of induced pluripotent stem cells, and the development of gene-editing tools, have enabled us to model CVD, but more importantly, may represent tools for CVD early diagnosis, patient stratification, and treatment.

AB - Cardiovascular disease (CVD) is still the leading cause of death worldwide, but the knowledge and technologies for counteracting this disease may already be in our hands. Scientific advances over the past few years, such as the isolation and differentiation of induced pluripotent stem cells, and the development of gene-editing tools, have enabled us to model CVD, but more importantly, may represent tools for CVD early diagnosis, patient stratification, and treatment.

UR - http://hdl.handle.net/10754/628249

UR - https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.312676

UR - http://www.scopus.com/inward/record.url?scp=85056529731&partnerID=8YFLogxK

U2 - 10.1161/circresaha.118.312676

DO - 10.1161/circresaha.118.312676

M3 - Article

C2 - 29976689

SN - 0009-7330

VL - 123

SP - 221

EP - 223

JO - Circulation Research

JF - Circulation Research

IS - 2

ER -

At the Heart of Genome Editing and Cardiovascular Diseases

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this